Next Article in Journal
Synthesis and Biological Activity Characterization of Novel 5-Oxopyrrolidine Derivatives with Promising Anticancer and Antimicrobial Activity
Next Article in Special Issue
Development of a Silicone-Based Polymer Matrix as a Suitable Transdermal Therapeutic System for Diallyl Disulfide
Previous Article in Journal
Skin Anti-Aging Potential of Ipomoea pes-caprae Ethanolic Extracts on Promoting Cell Proliferation and Collagen Production in Human Fibroblasts (CCD-986sk Cells)
Previous Article in Special Issue
Microneedle-Based Natural Polysaccharide for Drug Delivery Systems (DDS): Progress and Challenges
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

The Effect of Various Poly (N-vinylpyrrolidone) (PVP) Polymers on the Crystallization of Flutamide

1
Department of Pharmacognosy and Phytochemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, 41-200 Sosnowiec, Poland
2
Institute of Chemistry, Faculty of Science and Technology, University of Silesia in Katowice, 40-007 Katowice, Poland
3
Institute of Material Science, Faculty of Science and Technology, University of Silesia in Katowice, 41-500 Chorzów, Poland
4
Institute of Physics, Faculty of Science and Technology, University of Silesia in Katowice, 41-500 Chorzów, Poland
5
Department of Organic Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, 41-200 Sosnowiec, Poland
*
Authors to whom correspondence should be addressed.
Pharmaceuticals 2022, 15(8), 971; https://doi.org/10.3390/ph15080971
Submission received: 13 July 2022 / Revised: 1 August 2022 / Accepted: 3 August 2022 / Published: 6 August 2022

Abstract

:
In this study, several experimental techniques were applied to probe thermal properties, molecular dynamics, crystallization kinetics and intermolecular interactions in binary mixtures (BMs) composed of flutamide (FL) and various poly(N-vinylpyrrolidone) (PVP) polymers, including a commercial product and, importantly, samples obtained from high-pressure syntheses, which differ in microstructure (defined by the tacticity of the macromolecule) from the commercial PVP. Differential Scanning Calorimetry (DSC) studies revealed a particularly large difference between the glass transition temperature (Tg) of FL+PVPsynth. mixtures with 10 and 30 wt% of the excipient. In the case of the FL+PVPcomm. system, this effect was significantly lower. Such unexpected findings for the former mixtures were strictly connected to the variation of the microstructure of the polymer. Moreover, combined DSC and dielectric measurements showed that the onset of FL crystallization is significantly suppressed in the BM composed of the synthesized polymers. Further non-isothermal DSC investigations carried out on various FL+10 wt% PVP mixtures revealed a slowing down of FL crystallization in all FL-based systems (the best inhibitor of this process was PVP Mn = 190 kg/mol). Our research indicated a significant contribution of the microstructure of the polymer on the physical stability of the pharmaceutical—an issue completely overlooked in the literature.

Graphical Abstract

1. Introduction

Polymers are long-chain organic substances consisting essentially of repeated chemical units (called “mers”) linked together [1]. Based on origin, one can distinguish three main classes of these compounds: natural (e.g., cellulose and collagen), semisynthetic (e.g., (hydroxypropyl) methylcellulose (HPMC)) and synthetic (poly(N-vinylpyrrolidone) (PVP), poly(ethylene glycol) (PEG) and polystyrene (PS)) [2,3]. Polymers from each group play essential and ubiquitous roles in everyday life [4]. Moreover, some of them (exclusively non-toxic, biocompatible and physiologically inert macromolecules, accepted by Food and Drug Administration (FDA) and European Medicines Agency (EMA)), have application in pharmaceutical and biomedical industries, e.g., for drug protection, taste masking, targeted delivery or the controlled release of a given active substance, and also as tablet binders, solubilizers, emulsifiers, film coating agents (in solid dosage forms) and so on [1,2,3]. Among them, there are, e.g., vinyl lactam-based (co)polymers (i.e., PVP [5,6,7] and its copolymer with vinyl acetate (PVP/VA) [8], Kollidon®VA64/PlasdoneTMS-630 [9,10]; poly(vinyl caprolactam)-poly(vinyl acetate)-poly(ethylene glycol) graft copolymer (Soluplus) [7,11]); poly(methacrylate)s derivatives (Eudragit® L100-55, L100, S-100 and EPO grades) [5,12,13]; cellulose derivatives (HPMC [5,14,15], (hydroxypropyl) methyl cellulose acetate succinate (HPMCAS) [5,14]); and poly(ethylene glycol)s (PEG) [16,17,18]), which are used for the preparation (generally using methods based on solvent evaporation or melt cooling [19]) of amorphous solid dispersions (ASDs)/binary mixtures (BMs) with poorly water-soluble active pharmaceutical ingredients (APIs) from II and IV groups of Biopharmaceutical Classification System (BCS) [20,21].
Importantly, such a procedure results in improving apparent solubility/dissolution rates and, consequently, the bioavailability of drug substances (due to the fact that APIs in the amorphous form have no long-range crystallographic order and are characterized by higher free energy and greater chemical and thermodynamic activity as compared to the crystalline substances [22]). It is worth emphasizing that a given polymer that is physically and chemically stable, acts as an inactive stabilizer (a crystallization inhibitor) for disordered/labile pharmaceuticals in the ASD [14,23]. The physicochemical stabilization with its use results mainly from increasing the glass transition temperature, Tg (and consequently reducing molecular mobility of the system), as well as from strengthening intermolecular interactions between API and macromolecule (causing inhibition of nucleation and crystal growth) [24,25]. However, it should be added that this finding may also be affected by other factors, such as configurational entropy and enthalpy, Gibbs-free energy, humidity, mechanical stress and preparation methods (and conditions, e.g., cooling rate) [26]. Herein, one can also mention the volume fraction effect, which is important in the case of hybrid polymer-based nanocomposites. In such systems, the suppressed crystallization of the polymers, as well as self-assembly of the nanoparticles, has been discussed as related to this phenomenon [27,28,29,30]. Among FDA (or EMA)-approved medical preparations that are based on ASDs, one can list Modigraf® (Tacrolimus/HPMC), Novir® (Ritonavir PVP-VA), CesametTM (Nabilone-PVP), Cymbalta® (Duloxetine/HPMCAS) or Gris-PEG™ (Griseofluvin/PEG) [23].
Besides the beneficial properties of the polymers mentioned above, there are essential problems connected with the development of ASDs such as (i) the poor solubility of the drug in the polymer matrix (which results in the incorporation of a larger amount of excipient and, hence, increasing the final dosage form volume) and the (ii) high hygroscopicity of the macromolecule (which affects the molecular mobility of the active substance) [31,32]. Moreover, due to the high molar-mass distribution (i.e., high dispersity) in the case of several commercially available macromolecules (e.g., PVP—a water-soluble and biocompatible) or different degrees of the substitution of functional groups (cellulose derivatives, e.g., HPMC), there is a risk of phase microseparation in ASDs, resulting in the recrystallization of the incorporated amorphous pharmaceutical. In this context, it seems reasonable to synthesize and use polymers with strictly controlled parameters (i.e., low/moderate dispersity (Đ), tailored molecular weight (Mn), high functionality, chain-end fidelity, etc.) to obtain homogeneous, stable solid dispersions with desirable pharmacokinetic properties.
In this paper, we present the results of calorimetric, dielectric and infrared studies carried out on ASDs composed of flutamide, FL (an anticancer drug for prostatic carcinoma, belonging to BCS class II), with linear PVPs. Basically, three different PVPs (that is (i) commercially supplied PVP K90 (PVPcomm.) obtained in an aqueous solution, (ii) self-synthesized PVP via high-pressure free-radical polymerizations (HP-FRP) in bulk—a novel synthetic methodology, which enables the preparation of well-defined PVP of high purity using the “greenest” synthetic strategy [33,34], and (iii) self-synthesized hydroxyl-terminated PVP (PVP-OH) via HP CT-FRP mediated by 2-isopropoxyethanol, acting simultaneously as a solvent and chain-transfer agent, CT) have been the subject of our research. The full characteristic of these macromolecules, including 1H, 13C NMR and SEC analyses, is presented in the Supplementary Materials (Figures S1, S2 and S4). In particular, in our studies, we focus on determining the impact of these excipients, with defined macro- and micro-(structural) parameters, on the progress and activation barrier for crystallization, as well as characterizing intermolecular interactions in the examined BMs.
It should be mentioned that FL has been previously investigated in amorphous binary systems with polymers such as Kollidon®VA64 [35,36], poly(vinyl acetate) (PVAc) [37], PVP K90 (a commercial sample, produced at 0.1 MPa, for which the number average molecular weight (Mn) and Đ are poorly controlled), HPMC, Eudragit EPO, PEG 8000 [38] and in ternary mixtures with bicalutamide and poly(methyl methacrylate-co-ethyl acrylate) (MMA/PEA) or PVP K90 [39]. The subject of these studies was not only the influence of a given macromolecule on the physical stability/crystallization tendency but also a determination of the solubility of FL in the selected polymer matrices (with the use of broadband dielectric spectroscopy, both at ambient and high-pressure conditions), as well as studying the interactions between components of BMs and the effect of various polymers on FL precipitation. Herein, for the first time, various PVPs (including a hydroxyl-terminated derivative of this polymer, PVP-OH) with tailored Mn (=190 kg/mol or 90 kg/mol) and strictly controlled parameters (dispersity and chain-end fidelity) were applied to form ASDs with FL. Note that, previously, such macromolecules (with linear and star-shaped topologies [33,34]), produced via solvent-free HP strategy, have been used by some of us to form micellar drug delivery systems with metronidazole (MTZ) and to examine how these matrices affect the amorphization of API, its encapsulation, the stability of MTZ-loaded micellar structures and their in vivo release from the carrier [40].

2. Results and Discussion

As a first, we have carried out calorimetric measurements on neat FL, various PVPs (including PVP-OH derivative)—see Figure 1 and their mixtures (with 10 and 30 wt% of the second component). It should be noted that we did not examine binary systems with a higher content of PVP due to miscibility limitations (see the Materials and Methods section). DSC curves obtained upon heating the glassy samples are presented in Figure 2 (panels a–d).
As illustrated, the thermogram of each polymer (see the insets) reveals a single thermal event corresponding to the glass transition at Tg close to 450 K. In turn, in the case of neat FL and its ASDs with different PVP/PVP-OH content, besides the liquid-glass transition at lower T, there are additional peaks related to cold crystallization (exothermic process) and melting (endothermic process), respectively. The exception is FL+30 wt% PVP (Mn = 190 kg/mol) and FL+PVP (Mn = 90 kg/mol) systems, where such additional thermal events are not detected. Hence, it can be concluded that these two new synthetized PVPs (with controlled Mn and Ð), in contrast to PVPcomm., inhibit FL crystallization from the amorphous state when its content in the mixture is sufficiently high (30 weight percent). In the context of PVPcomm. (Mw = 340 kg/mol, Mn = 109 kg/mol), it is worth mentioning that the same polymer (available in the market) but with lower Mw (=58 kg/mol) was an effective stabilizer of amorphous FL at nearly the same concentration (strictly 29 wt%) of the polymer [37]. One can suppose that the slow down of the crystallization in the case of the two examined systems herein (>30 wt% of PVPsynt. Mn = 90 and 190 kg/mol) can be related to the greater volume fraction of polymers. Importantly, a similar phenomenon was argued to be responsible for the suppression of the polymer crystallization and self-assembly process of nanoparticles in polymer-based nanocomposite materials [28,29,30].
The values of Tg determined from DSC studies for examined BMs and neat FL are presented in panel (e) of Figure 2. It is well-observed that the glass transition temperature increases with the increasing content of the polymer in each mixture. Interestingly, the difference between TgDSC of FL+10 wt% and FL+30 wt% of PVPcomm. systems is negligible (ΔTgDSC = 1 K). On the other hand, the more significant difference (ΔTgDSC = 20–30 K) occurs for the other mixtures. This is a quite intriguing finding that cannot be explained considering only variations in Ð or Mn between commercial and synthesized PVPs. There must be other important factors that are responsible for such a peculiar change of the Tg between considered solid dispersions.
To explain this peculiarity, one needs to realize that the Tg of PVP is quite sensitive to the presence of unreacted monomer, moisture, and the implemented preparation strategy (character of initiating species, bulk vs. solvent polymerization). Interestingly, by manipulating all these parameters, we can directly affect the PVP molecular weight, dispersity, cross-linking degree and branching caused by chain-transfer processes [41]. However, considering that the Tgs of all recovered polymers were close to each other and collected NMR spectra revealed their high purity (lack of additional signals coming from unreacted monomer, water, solvent, etc.), the above-mentioned argumentation must be rejected. The other important factor that may influence the evolution of the Tg in BMs is stereoregularity (syndio, iso- or atactic arrangement of the lactam moiety along the main chain) of the produced PVPs. In this context, it is worth stressing that, currently, it is well-established that a polymer microstructure can depend on both “internal” (e.g., solvents/additives polarity/density) and “external” factors (e.g., given values of high pressure/temperature). For example, PVPs produced via thermally induced radical polymerization (p = 0.1 MPa) are mostly atactic [42]. In the vinyl pyrrolidone (VP) polymerization conducted in the presence of fluoroalcohols/anionic surfactants, some increase in syndiotacticity can be observed [43]. In turn, the implementation of Lewis acid catalysts to VP FRP increases the PVP’s isotacticity [44]. These phenomena are mostly related to electron pair donor–acceptor interactions between VP and given additives. Importantly, even though the stereoregularity of PVP seems to be a very important parameter describing its microstructure. The above issue is barely investigated and almost overlooked in the literature, especially in the cases in which this polymer is applied in pharmaceutical formulations of disordered APIs. The reason of such situation is the fact that there is only one leading supplier of PVP on the market. Hence, the microstructure of delivered macromolecules is assumed to be invariant since the same synthesis strategy is adopted for their production. The situation becomes less clear when we compare PVPs obtained via different methods, such as herein by applying high pressure. Therefore, to describe the microstructure of the polymers used to prepare binary mixtures, carbon-13C nuclear magnetic resonance spectra (13C NMR in D2O) of the investigated commercial and synthesized PVPs [45,46] (see the SM) were analyzed in detail. Notably, PVPs (Mn = 190 kg/mol and 90 kg/mol) and PVP-OH samples produced by us (via HP-FRP and HP CT-mediated FRP, respectively) revealed ultra-high purity (lack of moisture and uncreated monomer), and the only difference between them was the presence or absence of the solvent during their preparation. The obtained results (analysis of triad and tetrad sequences) are presented in Figure 3 and Figure S3. Let us take a look firstly at the microstructure of PVPcomm. determined by the 13C NMR carbonyl region (see Figure 3). As illustrated, the PVPcomm. (PVP K90) sample is dominated by atactic fractions, with a relatively high content of isotactic ones, and this result is in line with other findings in the literature [47]. In turn, samples synthesized herein, i.e., PVP with Mn = 190 and 90 kg/mol (produced via solvent-free HP-FRP, 250 MPa) showed a significant increase in isotactic fractions, i.e., 15–16%. Similar conclusions were derived from the analysis of tetrad sequences determined from β-methylene protons (13C NMR, D2O, please see Figure S3). The above effect (i.e., an increase in the number of isotactic units) was previously reported for HP-FRP of methyl methacrylate [48] or sterically congested α-acrylates [49]. Finally, a short note should be added to PVP-OH prepared via thermally initiated HP (p = 250 MPa) reactions, in which an additional alcoholic chain transfer agent (2-isopropoxyethanol) was used. Interestingly, when analyzing this sample, we noticed that the number of isotactic fractions is slightly lower than those noted for PVPs synthesized via solvent-free HP-FRP (Mn = 190 kg/mol and 90 kg/mol), but at the same time, it was significantly higher than that observed in PVPcomm. It seems clear to us that the simultaneous action of solvent and high-pressure was responsible for this result. Without mentioning specific details, it should be summarized that gaining control over polymer tacticity is a reasonably complex aspect influenced by many factors.
Interestingly, the mentioned differences in the tacticity do not significantly affect the glass transition temperature of the studied polymers (they are characterized by a similar Tg, in the range 449–452 K). Hence, obtained results stay in contrast to the literature data showing that there are normally much greater variations in the Tg of more or less polar macromolecules (e.g., poly(methyl methacrylate) (PMMA), poly(2-methoxyethylacrylate) (PMEA) [50,51,52,53], polystyrene [54], etc. [55]), differing in tacticity (i.e., with various content of isotactic (i), syndiotactic (s) and atactic (a) fractions in the sample). Moreover, in the case of polypropylene, a variation in the microstructure leads to a change in the degree of crystallinity and mechanical properties [55]. The observed discrepancies might be related to the highly polar character of PVP and, contrary to the other polymers, its highly hydrophilic nature. One can also suppose that the residual water, which is always present in the structure of this polymer (it is very difficult to remove it even by heating/annealing), can weakly interact via H-bonds with the molecules of macromolecule. For this reason, the effect of Tg of PVP on tacticity is clearly lower when compared to other mentioned polymers.
On the other hand, to the best of our knowledge, the correlation between the tacticity of a given polymer and the Tg of the BM formed by low molecular weight substance (including API) and the macromolecule has not been investigated so far. There are only reports on blends composed of PMMA with various tacticities, i.e., a-PMMA/s-PMMA, i-PMMA/s-PMMA, as well as a-PMMA/i-PMMA [56,57]. It should be noted that in these papers, the analysis of the Tg of the binary system versus s-PMMA or a-PMMA (wt%) in the mixtures revealed a marked increase in the glass transition temperature (about 85 K in the two latter cases and 17 K in a-PMMA/s-PMMA mixture) with increasing contents of a given conformer in the blend. One can suppose that the results determined for FL+PVPcomm. and FL+other PVPs mixtures (i.e., small or large variations, respectively, between Tg of the systems with 10 and 30 wt% of the excipient) may be explained considering differences in the tacticity (the content of respective fractions) of the polymer forming ASDs.
After calorimetric studies, we have carried out dielectric spectroscopy measurements to characterize the molecular dynamics of FL and FL+10% wt. PVP (PVP-OH) systems and checked at which T the crystallization process occurs. Note that due to the fact that there were no traces of crystallization in thermograms registered for all considered FL + 30 wt% polymer mixtures, such experiments were not performed on those samples. The results of BDS measurements (ε′′ vs. frequency (f) dependencies) carried out in a wide temperature range are presented in panels a–e in Figure 4. As illustrated, except for the DC-conductivity (DC), the spectra registered at T > Tg exhibit one well-resolved loss peak corresponding to the structural (α)-relaxation, which moves towards higher f with increasing T. In Figure 5a, we compared the shape of α-process for FL and all examined mixtures at the indicated T close to Tg (the maxima of the peaks near 1 Hz) by fitting the presented data by means of the one-sided Fourier transform of the Kohlrausch–Williams–Watts (KWW) function [58,59] (solid lines). It turned out that the presence of a small amount of each polymer results in a broadening of α-dispersion (compared to neat FL, for which the stretched exponent, βKWW = 0.86). The lowest values of this parameter (which means the broadest structural peak) were obtained for BMs with two synthesized PVP: Mn = 190 kg/mol and 90 kg/mol (0.63 and 0.65, respectively). Slightly higher βKWW (~0.70) was determined for two other mixtures, i.e., with PVPcomm. and PVP-OH.
We have also analyzed the spectra of each system presented in Figure 4 with the use of the Havriliak–Negami function [60]:
ε   ω = σ D C ε 0 ω + ε + ε 1 + i ω τ H N a b
where ε0 is the vacuum permittivity, σ D C is the dc-conductivity, ω (=2πf) is the angular frequency, ε is the high-frequency limit permittivity, ε is the dielectric strength, τHN is the HN relaxation time and a and b represent the symmetric and asymmetric broadening of the given relaxation peak. Then, based on the fitting parameters determined above, structural relaxation times (τα) were calculated from the following formula [60]:
τ α = τ H N s i n a π 2 + 2 b 1 / a s i n ab π 2 + 2 b 1 / a
and next plotted as a function of 1000/T in Figure 5b. We further fitted these dependencies by the Vogel–Fulcher –Tammann function:
τ α = τ V F T e x p D T T 0 T T 0 ,
where τ V F T is the relaxation time at finite temperature and D T is the strength parameter or fragility, whereas T 0 represents T at which τ α tends to infinity, we determined Tg (here defined as a T at which τα = 100 s) for FL and each FL+ 10 wt% polymer system. As observed in Figure 5b and Figure 2e, as well as in Table 1, there is a good correspondence between TgBDS and TgDSC (heating rate 10 K/min); ΔTg = ±3 K. Moreover, the values of this parameter for FL+PVP Mn = 190 kg/mol and FL+PVP Mn = 90 kg/mol systems are slightly higher than the Tg of FL+PVP-OH and FL+PVPcomm. mixtures.
Importantly, from Figure 4, it can be observed that the onset of the crystallization process in FL+10 wt% PVPcomm., reflected in the lowering amplitude of the α-process, occurs at 297 K, which is barely 2 K higher than Tonset in a neat FL system. On the other hand, for the three other BMs (containing synthesized polymers: PVP Mn = 90 kg/mol, PVP Mn = 190 kg/mol and PVP-OH), the crystallization of API begins at higher T: 311, 307 and 301 K, respectively). It is well-visualized in panel (f) of Figure 4, presenting the difference between Tonset and Tg for FL and all considered mixtures.
To verify how a given polymer influences the progress and activation barrier of FL crystallization in the examined systems, we carried out non-isothermal calorimetric measurements. DSC curves measured with various heating rates ( ϕ ) for neat FL and FL+10 wt% PVP Mn = 190 kg/mol system are shown in panels (a) and (b) of Figure 6. Analogical data for three other BMs are presented in Figure S5. It is well-observed that there are two or three endothermic processes in the thermograms collected at 5, 10, 20 and 30 K/min heating rates ( ϕ ). The first one, which emerges at lower T, is associated with the glass-transition event. In turn, the other ones (one in the case of neat FL and its binary system with PVPcomm., PVP-OH; two in the case of FL+PVP Mn = 190 kg/mol and FL+PVP Mn = 90 kg/mol mixtures) are related to the melting process. Moreover, in all samples, for each ϕ , the presence of an exothermic event indicating the crystallization of FL can be observed.
Based on the results of non-isothermal crystallization experiments carried out at various ϕ , the relative degree of crystallinity ( X ) as a function of T has been obtained:
X T = T 0 T d H c / d T d T / T 0 T d H c / d T d T ,
where d H c represents the enthalpy of crystallization released during an infinitesimal temperature interval and T 0 denotes the initial crystallization temperature, while T and T denote the crystallization temperature at time t and the temperature at the end of the crystallization process. Representative data (X vs. T dependence) for neat FL are provided in Figure S6a.
Having X T for each system, we were able to determine X t by transforming the temperature axis to the time (t) axis using the following formula [61].
t = T T 0 / ϕ
The plots of a relative degree of crystallinity against crystallization time t at different ϕ for neat FL and FL+10 wt% PVP Mn = 190 kg/mol system are shown in panels (a) and (b) of Figure 7, while analogical data for other BMs are presented in Figure S7. As observed, in each case, the crystallization slows down with decreasing heating rates. Moreover, the curves determined for each binary system at lower ϕ (5 and 10 K/min) seem to have a different shape than those of neat FL registered at the same ϕ . This might suggest the two-stage crystallization process. To determine constant rates of non-isothermal crystallization in a neat API (FL) system, the Avrami equation was applied [62,63]:
X t = 1 exp k 1 t n
where k 1 is a rate constant, and n is the Avrami exponent, which depends on the crystal morphology and crystallization mechanism [64].
In turn, for FL+10 wt% PVP/PVP-OH mixtures, due to the inability to obtain a good fit with the use of Equation (6), we have used the following expression:
X t = 1 x   exp k 1 t n 1 x e xp k 2 t m
which is a modification of the Avrami model for considering two-stage crystallization (herein named “double Avrami” model). x in Equation (7) parametrizes the relative contributions of each crystallization step and k 1 and k 2 are rate constants, while n and m are fit parameters. It is worth pointing out that according to the literature reports on a two-stage crystallization process (however taking place from solution/fluid, not from the solid state), in the first step, dense liquid (disorder) clusters are formed, while in the second step, the molecules in the mentioned clusters rearrange their orientations to form ordered nuclei (crystals). Such a mechanism, which was suggested also in the case of, e.g., triblock Janus assemblies [65,66,67], proteins [68], colloids [69] and biomaterials [70], is sometimes more favorable than the one-step formation of crystalline nuclei. However, it should be noted that since we measured solid-state systems, the two-stage process might be due to the change of one polymorphic form into another during the course of crystallization.
In panels (c) and (d) of Figure 7, dependences of log10 k 1 and log10 k 2 versus ϕ are presented. As illustrated (Figure 7c, Table 1), a small amount of each polymer (10 wt%) causes the slow down of FL crystallization. It is particularly noticeable at higher heating rates: 20 and 30 K/min (smaller k 1 when compared to that of neat FL). PVP Mn = 190 kg/mol is the excipient for which its impact on such behavior is the most significant (the lowest values of k 1 at each ϕ ; see Table 1). Comparing polymers with the same/nearly the same Mn, it can be stated that PVP Mn = 90 kg/mol and PVP Mn = 190 kg/mol, compared to PVPcomm. and PVP-OH, respectively, suppress/slow down the API crystallization a little bit more (Figure 7c). In the context of the constant rate k 2 , one can add that its value determined for all binary systems at a given ϕ was comparable (Table 1). It should also be mentioned that the values of the exponent n obtained from the analysis of the data for neat FL using Equation (6) and FL+10 wt% PVP (PVP-OH) using Equation (7) changed generally in the range of 2–3—a somewhat lower n (1.3–1.7) was determined only for neat FL at lower ϕ , see Table 1). In turn, the values of the parameter m (Equation (7)) were clearly higher and unreliable. Therefore, we will not present (in Table 1) and discuss them.
Subsequently, we have also calculated the activation energy of non-isothermal crystallization ( E c r ) for the examined FL+10 wt% polymer (various PVPs) BMs. For this purpose, the thermograms presented in Figure 6 and Figure S5 were analyzed with the use of two approaches, proposed, respectively, by Augis and Bennett [71] as well as Kissinger [72]. The former method considers the onset temperature of crystallization ( T o ).
l n ϕ T p T o = C A G E c r R T p
In turn, the latter one is based on the variation of the crystallization peak temperature ( T p ) with ϕ .
l n ϕ T p 2 = C K E c r R T p
C A G and C K in the above expressions (Equations (8) and (9)) are fitting parameters, while R is a gas constant. The obtained results (together with Ecr determined for each system) are presented in Figure 8. It should be noted that the values of T p and T o are provided in Table 1. As observed in Figure 8c, the Kissinger methods yielded a higher Ecr than the Augis–Bennett approach. Similar conclusions were derived from the analysis of the crystallization data obtained for other APIs/BMs, e.g., salol [73] or naproxen-acetylated saccharide systems [74]. Generally, the activation barrier for API crystallization in a system with 10 wt% of PVP comm. is relatively high and slightly smaller than that obtained for neat FL (Augis-Bennett:~150 kJ/mol, Kissinger~200 kJ/mol). For other mixtures, somewhat lower, comparable values of Ecr (Augis-Bennett: from 119–138 kJ/mol; Kissinger: from 167–182 kJ/mol) were determined. Based on the above, it can be concluded that the presence of each of the examined polymers (both commercial and synthesized samples) only slightly affects the Ecr. In the context of neat FL, it should be mentioned that the obtained Ecr is significantly greater when compared to the values calculated using the Augis–Bennett and/or Kissinger approaches for other APIs, e.g., sildenafil (Ecr~100–120 kJ/mol) [75], carbamazepine (Ecr~100 kJ/mol for ϕ > 7.5 K/min) [76], salol (Ecr~80–90 kJ/mol) [73] or biclotymol (Ecr~50 kJ/mol) [77]. One can mention ketoprofen, for which an even higher Ecr from the Kissinger method (~264 kJ/mol) with respect to that obtained for FL was determined [78].
Aside from the molecular dynamics studies and crystallization kinetics, we also applied ATR-FTIR spectroscopy to get insight into intermolecular interactions occurring between FL molecules and PVP/PVP-OH polymers. The representative spectra of neat API and API-based BMs in two frequency regions, 3800–2500 cm−1 and 1800–400 cm−1, are shown in Figure 9. However, firstly, the amorphous FL sample was spectroscopically characterized to recognize/identify the bands arising from hydrogen bonds. Based on the literature data, it is known that FL molecules in the crystalline state are intermolecularly linked by classical N-H···O hydrogen bonds linking one oxygen of the nitro group and the hydrogen of the amide group [79]. Moreover, aromatic hydrogen atoms are involved in C-H···O intermolecular hydrogen bonds with nitro or amide oxygen atoms generating a bifurcated helicoidal hydrogen-bond network. Thus, these functional groups (amide or carbonyl moieties) may have the potential to interact with polymers through the hydrogen bond. As shown in Figure S8, the FTIR spectrum of the crystalline FL confirms the formation of H-bonds by amide groups as the spectral region in the high frequency is dominated by the main peak at 3355 cm−1. Several peaks are relatively simple to attribute in this spectrum, such as those at 3130–3000 cm−1 (aromatic C–H stretches), 3000–2800 cm−1 (aliphatic C-H stretches), 1714 cm−1 (C=O stretch), 1611 cm−1 (C-C and O-N stretch), 1494 cm−1 (HNC deformation), 1313 cm−1 (C-C stretch), 1173 cm−1 (F-C stretch) and 1139 cm−1 (N-C and F-C stretches). A detailed assignment of the IR vibrational bands of crystalline FL was presented in ref. [80]. Compared to the crystalline FL, the ATR-FTIR spectrum obtained for the amorphous API (Figure S8) showed several significant differences, i.e., the narrow peak at 3355 cm−1 assigned to the N-H stretching of the amide group is significantly broadened and slightly shifted to lower wavenumbers (two peak maxima at 3309 and 3294 cm−1), while the band related to the C=O stretching from the amide group shows a shift from 1714 to 1678 cm−1 and consists of two signals of varying intensity. Moreover, there is a change at the 1640–1370 cm−1 spectral region of glassy FL, in which some bands exhibit smaller intensity (1617, 1545, 1497 and 1387 cm−1) while other new ones appear (1520 and 1416 cm−1). Generally, the broadening of most IR bands is associated with a disorder and re-organization of the supramolecular structure of the amorphous network of neat API. In the case of amorphous FL-based systems containing different PVPs, the changes in the profile of N-H stretching band are detected. As can be observed in Figure 9 and Figure S9, the N-H band in the IR spectrum of neat amorphous FL has two maxima at 3309 and 3294 cm−1, while the shoulder at higher frequencies partially disappears in FL+PVP mixtures. Additionally, a subtle difference between FL and binary systems was observed in the region of 3185–3025 cm−1 assigned to aromatic C-H stretching vibrations (Figure 9). It should be observed that the broadness of this band for FL+10 wt% PVP (Mn = 90 kg/mol) mixture appears to be larger than those for the other BMs. On the other hand, the same system is characterized by the lowest intensity of the N–H band shoulder at 3309 cm−1. Thus, spectroscopic results reveal that PVP Mn = 90 kg/mol may have the greatest effect on the association of drug molecules compared to the other polymers. Similar conclusions from IR spectra analyses were reported in ref. [38] for the FL+PVP K90 system. Moreover, BMs of FL and various PVPs show a higher intensity of the C=O band occurring at 1740–1700 cm−1 than the neat API. These little spectral differences between pharmaceutical and solid dispersions, only concerning the bands involved in the formation of H-bonds between FL molecules, may suggest a disturbance of the association of API molecules in the environment of polymers. On the other hand, there are no significant differences in the position of the bands originating from FL molecules in the spectra of the mixtures, and there are no new peaks indicating the existence of intermolecular interactions between the components of the BM. At this point, it should be mentioned that, in the analyzed spectral regions, there is no overlapping the bands originating from PVP (see Figure S9), so the observed spectral changes are only related to the impact of a polymer additive on hydrogen bonding in the amorphous API.

3. Materials and Methods

3.1. Materials

Flutamide (molecular weight, Mw = 276.2 g/mol, purity greater than 99%) and commercially available poly(N-vinylpyrrolidone), PVP K90 (PVPcomm., Mw = 340 kg/mol, average molecular weight, Mn~109 kg/mol), were purchased from Sigma-Aldrich and used as received. Two linear PVPs with different Mn (=90 kg/mol and 190 kg/mol) as well as hydroxyl-terminated PVP (PVP-OH) with Mn = 190 kg/mol were synthesized for the purpose of this paper (for details concerning the synthesis procedure, see the Supplementary Materials and References [33,81].

3.2. Preparation of Binary Mixtures

The FL-polymer amorphous binary systems were prepared at different weight concentrations of PVP (PVP-OH) in each sample (10, 30, 50 and 70 wt% of the excipient). To obtain homogeneous samples, we mixed FL with a given PVP (PVP-OH) polymer at appropriate ratios in mortar for 20–30 min. Next, the obtained mixtures were melted at T~390 K during the first DSC scan and vitrified by cooling at a rate of 10 K/min during the second DSC scan (standard calorimetric measurements). It should be noted that preliminary miscibility tests and DSC investigations confirmed that only mixtures with 10 and 30% of the polymer are homogeneous. In the systems with a higher content of EXC (>50%), both components, API and polymer, did not mix with each other (the phase separation was noticeable).
Sample preparations for BDS and FTIR studies (only systems with 10 and 30 wt% of the excipient) involved melting at T~390 K followed by vitrification on a previously chilled copper plate. All measurements were performed immediately after the preparation of the amorphous BMs to avoid recrystallization.

3.3. Differential Scanning Calorimetry (DSC)

Calorimetric measurements of FL, various PVPs (including PVP-OH) and their BMs were performed using a Mettler-Toledo DSC apparatus. This device was equipped with a liquid nitrogen cooling accessory and an HSS8 ceramic sensor having 120 thermocouples. The instrument was calibrated for temperature and enthalpy using indium and zinc standards. The samples were placed in an aluminum crucible (40 μL). Measurements were performed in a temperature range from 260 K to 490 K at a constant heating/cooling rate of 10 K min−1.
Non-isothermal calorimetric measurements (heating rates from 5 to 30 K/min) were carried out on FL+10 wt% PVP (and PVP-OH) BMs immediately after the preparation of amorphous samples. For each experiment, a fresh sample was prepared.

3.4. Broadband Dielectric Spectroscopy (BDS)

The dielectric measurements of FL-based BMs were carried out using a Novo-Control GMBH Alpha dielectric spectrometer (Novocontrol Technologies GmbH & Co. KG, Hundsangen, Germany) in the frequency range from 10−2 Hz to 106 Hz. The temperature stability controlled by the Quatro System using a nitrogen gas cryostat was better than 0.1 K. Dielectric studies of FL and FL+10 wt% PVP (and PVP-OH) systems were performed immediately after their vitrification in a parallel-plate cell made of stainless steel (diameter 20 mm and 0.1 mm gap with a quartz spacer). Measurements were carried out in a temperature range of 253–317 K.

3.5. Fourier Transform Infrared (FTIR) Spectroscopy

The infrared absorption spectra were recorded on a Nicolet™ iS50 Fourier Transform Infrared (FTIR) spectrometer equipped with the built-in diamond Attenuated Total Reflection (ATR) accessory. Each spectrum was the average of 32 scans measured with a spectral resolution of 4 cm−1.

3.6. Nuclear Magnetic Resonance (NMR) Spectroscopy

1H and 13C NMR spectra were collected on a Bruker Ascend 500 MHz spectrometer for the samples in CDCl3 or D2O with a TMS internal standard at 25 °C.

3.7. Size Exclusion Chromatography (SEC)

Molecular weights (Mn) and dispersities (Ð) of PVPs were determined by gel permeation chromatography (GPC) with a Viscotec GPC Max VR 2001 and a Viscotec TDA 305 triple detection-containing refractometer, viscosimeter and low-angle laser-light scattering. The OmniSec 5.12 was used for data processing. Two T6000M general mixed columns were used for separation. The measurements were carried out in DMF (+10 mmol LiBr) as the solvent at 50 °C with a flow rate of 0.8 mL/min. For details (SEC traces of different PVPs used as matrices for FL), see Figure S4. Dispersities of PVP K90 (Mn = 109 kg/mol), PVP (Mn = 190 kg/mol), PVP (Mn = 90 kg/mol) and PVP-OH (Mn = 190 kg/mol) determined from chromatographic measurements were as follows: Đ = 1.78, Đ = 1.86, Đ = 1.47 and Đ = 1.63, respectively.

4. Conclusions

In this paper, we examined amorphous BMs composed of FL and various PVPs (commercial PVP K90 and synthesized samples) with the use of DSC, BDS and FTIR methods. Calorimetric measurements revealed that in contrast to FL+PVPcomm. solid dispersion, for other FL-based mixtures, there is a large variation between the Tg of the system with 10 and 30 wt% of the excipient. It was suggested that, most likely, the differences in the tacticity of the polymer forming amorphous BMs are responsible for that. Interestingly, such variations in the tacticity did not significantly affect the Tg of the studied PVPs themselves, which was in contrast to the literature data reported so far for several polymers. DSC investigations also showed that at higher (i.e., 30 wt%) contents of two new-synthesized polymers, contrary to PVPcomm., the crystallization of FL from the amorphous state is suppressed. Moreover, these studies, together with BDS ones, indicated that, in the mixture with 10 wt% of PVPcomm., FL starts to crystallize at a similar T to that of the neat API system. In turn, this process begins at a higher T in BMs with other PVPs. Further non-isothermal calorimetric measurements carried out on various FL+10 wt% PVP systems demonstrated that a small amount of each polymer (the most PVP Mn = 190 kg/mol) causes the slow down of FL crystallization. It was particularly visible at higher heating rates, i.e., 20 and 30 K/min. The analysis of the collected thermograms with the use of Augis–Bennett and Kissinger approaches revealed that the presence of both commercial, as well as new-synthesized PVPs, only slightly affects the activation energy of non-isothermal crystallization. Finally, infrared investigations demonstrated some small spectral differences, however, only in the bands involved in the formation of H-bonds between API molecules in the examined FL+10 wt% PVP mixtures (the most visible in the case of the BM with PVP, Mn = 90 kg/mol) compared to a neat API system. Based on these results, it was suggested that there is a disturbance of the association of API molecules in the environment of polymers. The studies presented herein clearly emphasized that the microstructure of the polymer seems to be a very important parameter that, aside from the molecular weight or dispersity, may contribute to the physical stability of the active substance.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/ph15080971/s1. Details concerning the synthesis procedure of PVP-OH, size exclusion chromatography (SEC) and NMR analyses of various PVP/PVP-OH (including 13C NMR assignments of triad and tetrad stereosequences), non-isothermal calorimetric data for binary mixtures of FL with 10 wt% of PVPcomm., PVP Mn = 90 kg/mol and PVP-OH Mn = 190 kg/mol, as well as ATR-FTIR spectra measured for crystalline and amorphous FL, various PVP/PVP-OH and FL+10% wt. PVP/PVP-OH systems.

Author Contributions

D.H.: Formal analysis, investigation, methodology and visualization. B.H.: Investigation. P.M.: Investigation and resources. K.K.: Conceptualization. A.Z.: Investigation. L.O.: Investigation and resources. M.P.: Conceptualization. E.K.: Conceptualization, writing—original draft, supervision, project administration and funding acquisition. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded in whole by the National Science Centre (Poland), grant number: Opus 21 No. 2021/41/B/NZ7/01654. For the purpose of Open Access, the author has applied a CC-BY public copyright licence to any Author Accepted Manuscript (AAM) version arising from this submission.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data is contained within the article and Supplementary Materials.

Acknowledgments

The authors thank Krzysztof Chmiel for non-isothermal DSC measurements.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Chauhan, N.P.S.; Pathak, A.K.; Bhanat, K.; Ameta, R.; Rawal, M.K.; Punjabi, P.B. Pharmaceutical polymers. In Encyclopedia of Biomedical Polymers and Polymeric Biomaterials; Taylor and Francis: New York, NY, USA, 2016; pp. 5929–5942. [Google Scholar]
  2. Sanjay, P.D.; Vasantrao, P.P.; Pandit, D.P.; Dattaprasad, D.S.; Shivaji, M.S. Polymers used in pharmaceuticals: A brief review. Int. J. Pharm. Chem. Res. 2016, 2, 233–238. [Google Scholar]
  3. Jones, D. Pharmaceutical Applications of Polymers for Drug Delivery; iSmithers Rapra Publishing: Belfast, United Kingdom, 2004; ISBN 978-1-85957-479-9. [Google Scholar]
  4. McCrum, N.G.; Buckley, C.P.; Bucknall, C.B. Principles of Polymer Engineering; Oxford University Press: New York, NY, USA, 1997; ISBN 978-0-19-856526-0. [Google Scholar]
  5. Wegiel, L.A.; Mauer, L.I.; Edgar, K.J.; Taylor, L.S. Crystallization of amorphous solid dispersions of resveratrol during preparation and storage—Impact of different polymers. J. Pharm. Sci. 2013, 102, 171–184. [Google Scholar] [CrossRef] [PubMed]
  6. Safna Hussan, K.P.; Shahin Thayyil, M.; Deshpande, S.K.; Jinitha, T.V.; Manoj, K.; Ngai, K.L. Molecular dynamics, physical and thermal stability of neat amorphous amlodipine besylate and in binary mixture. Eur. J. Pharm. Sci. 2018, 119, 268–278. [Google Scholar] [CrossRef] [PubMed]
  7. Caron, V.; Hu, Y.; Tajber, L.; Erxleben, A.; Corrigan, O.I.; McArdle, P.; Healy, A.M. Amorphous solid dispersions of sulfonamide/Soluplus® and sulfonamide/PVP prepared by ball milling. AAPS Pharm. Sci. Tech. 2013, 14, 464–474. [Google Scholar] [CrossRef] [PubMed]
  8. Chen, Y.; Liu, C.; Chen, Z.; Su, C.; Hageman, M.; Hussain, M.; Haskell, R.; Stefanski, K.; Qian, F. Drug-polymer-water interaction and its implication for the dissolution performance of amorphous solid dispersions. Mol. Pharm. 2015, 12, 576–589. [Google Scholar] [CrossRef] [PubMed]
  9. Szafraniec-Szczęsny, J.; Antosik-Rogóż, A.; Kurek, M.; Gawlak, K.; Górska, A.; Peralta, S.; Knapik-Kowalczuk, J.; Kramarczyk, D.; Paluch, M.; Jachowicz, R. How does the addition of Kollidon®VA64 inhibit the recrystallization and improve ezetimibe dissolution from amorphous solid dispersions? Pharmaceutics 2021, 13, 147. [Google Scholar] [CrossRef] [PubMed]
  10. Song, Y.; Wang, L.; Yang, P.; Wenslow, R.M., Jr.; Tan, B.; Zhang, H.; Deng, Z. Physicochemical characterization of felodipine-kollidon VA64 amorphous solid dispersions prepared by hot-melt extrusion. J. Pharm. Sci. 2013, 102, 1915–1923. [Google Scholar] [CrossRef] [PubMed]
  11. Homayouni, A.; Sadeghi, F.; Nokhodchi, A.; Varshosaz, J.; Garekani, H.A. Preparation and characterization of celecoxib dispersions in Soluplus: Comparison of spray drying and conventional methods. Iran. J. Pharm. Res. 2015, 14, 35–50. [Google Scholar] [PubMed]
  12. Gangurde, A.B.; Kundaikar, H.S.; Javeer, S.D.; Jaiswar, D.R.; Degani, M.S.; Amin, P.D. Enhanced solubility and dissolution of curcumin by a hydrophilic polymer solid dispersion and its insilico molecular modeling studies. J. Drug Deliv. Sci. Technol. 2015, 29, 226–237. [Google Scholar] [CrossRef]
  13. Sandhu, H.; Shah, N.; Chokshi, H.; Malick, A.W. Overview of amorphous solid dispersion technologies. In Amorphous Solid Dispersions; Springer: New York, NY, USA, 2014; pp. 91–122. [Google Scholar]
  14. Chavan, R.B.; Rathi, S.; Jyothi, V.G.S.S.; Shastri, N.R. Cellulose based polymers in development of amorphous solid dispersions. Asian J. Pharm. Sci. 2019, 14, 248–264. [Google Scholar] [CrossRef] [PubMed]
  15. Liu, J.; Grohganz, H.; Rades, T. Influence of polymer addition on the amorphization, dissolution and physical stability of co-amorphous systems. Int. J. Pharm. 2020, 588, 119768. [Google Scholar] [CrossRef] [PubMed]
  16. Shi, Q.; Cheng, J.; Li, F.; Xu, J.; Zhang, C. Molecular mobility and crystal growth in amorphous binary drug delivery systems: Effects of low-concentration Poly(Ethylene Oxide). AAPS Pharm. Sci. Tech. 2020, 21, 317. [Google Scholar] [CrossRef] [PubMed]
  17. Shi, Q.; Zhang, C.; Su, Y.; Zhang, J.; Zhou, D.; Cai, T. Acceleration of crystal growth of amorphous griseofulvin by low-concentration poly(ethylene oxide): Aspects of crystallization kinetics and molecular mobility. Mol. Pharm. 2017, 14, 2262–2272. [Google Scholar] [CrossRef] [PubMed]
  18. Daravath, B.; Naveen, C.; Vemula, S.K.; Tadikonda, R.R. Solubility and dissolution enhancement of flurbiprofen by solid dispersion using hydrophilic carriers. Braz. J. Pharm. Sci. 2018, 53, e00010.B. [Google Scholar] [CrossRef]
  19. Kumar, K. Solid dispersion: Solubility enhancement technique of poorly water soluble drug. J. Drug Deliv. Ther. 2020, 10, 173–177. [Google Scholar]
  20. Pandi, P.; Bulusu, R.; Kommineni, N.; Khan, W.; Singh, M. Amorphous solid dispersions: An update for preparation, characterization, mechanism on bioavailability, stability, regulatory considerations and marketed products. Int. J. Pharm. 2020, 586, 119560. [Google Scholar] [CrossRef] [PubMed]
  21. Bhujbal, S.V.; Mitra, B.; Jain, U.; Gong, Y.; Agrawal, A.; Karki, S.; Taylor, L.S.; Kumar, S.; Zhou, Q.T. Pharmaceutical amorphous solid dispersion: A review of manufacturing strategies. Acta Pharm. Sin. B 2021, 11, 2505–2536. [Google Scholar] [CrossRef]
  22. Khodadadi, S.; Meesters, G.M.H. Amorphous APIs: Improved release, preparation, characterization. In Particles and Nanoparticles in Pharmaceutical Products: Design, Manufacturing, Behavior and Performance; Merkus, H.G., Meesters, G.M.H., Oostra, W., Eds.; Springer International Publishing: Cham, Switzerland, 2018; pp. 329–346. [Google Scholar]
  23. Vasconcelos, T.; Marques, S.; das Neves, J.; Sarmento, B. Amorphous solid dispersions: Rational selection of a manufacturing process. Adv. Drug Deliv. Rev. 2016, 100, 85–101. [Google Scholar] [CrossRef] [PubMed]
  24. Frank, D.S.; Matzger, A.J. Probing the interplay between amorphous solid dispersion stability and polymer functionality. Mol. Pharm. 2018, 15, 2714–2720. [Google Scholar] [CrossRef]
  25. Mistry, P.; Suryanarayanan, R. Strength of drug−polymer interactions: Implications for crystallization in dispersions. Cryst. Growth Des. 2016, 16, 5141–5149. [Google Scholar] [CrossRef]
  26. Baghel, S.; Cathcart, H.; O’Reilly, N.J. Polymeric Amorphous Solid Dispersions: A review of amorphization, crystallization, stabilization, solid-state characterization, and aqueous solubilization of biopharmaceutical classification system Class II drugs. J. Pharm. Sci. 2016, 105, 2527–2544. [Google Scholar] [CrossRef]
  27. Kumar, S.K.; Ganesan, V.; Riggleman, R.A. Perspective: Outstanding theoretical questions in polymer-nanoparticle hybrids. J. Chem. Phys. 2017, 147, 020901. [Google Scholar] [CrossRef] [PubMed]
  28. Jabbarzadeh, A. The origins of enhanced and retarded crystallization in nanocomposite polymers. Nanomaterials 2019, 9, 1472. [Google Scholar] [CrossRef] [PubMed]
  29. Jabbarzadeh, A.; Halfina, B. Unravelling the effects of size, volume fraction and shape of nanoparticle additives on crystallization of nanocomposite polymers. Nanoscale Adv. 2019, 1, 4704–4721. [Google Scholar] [CrossRef]
  30. Genix, A.-C.; Oberdisse, J. Nanoparticle self-assembly: From interactions in suspension to polymer nanocomposites. Soft Matt. 2018, 14, 5161–55179. [Google Scholar] [CrossRef] [PubMed]
  31. Kaushal, A.M.; Gupta, P.; Bansal, A.K. Amorphous drug delivery systems: Molecular aspects, design, and performance. Crit. Rev. Ther. Drug Carr. Syst. 2004, 21, 1–62. [Google Scholar] [CrossRef]
  32. Tian, Y.; Jones, D.S.; Andrews, G.P. An investigation into the role of polymeric carriers on crystal growth within amorphous solid dispersion systems. Mol. Pharm. 2015, 12, 1180–1192. [Google Scholar] [CrossRef] [PubMed]
  33. Maksym, P.; Tarnacka, M.; Heczko, D.; Knapik-Kowalczuk, J.; Mielanczyk, A.; Bernat, R.; Garbacz, G.; Kaminski, K.; Paluch, M. Pressure-assisted solvent- and catalyst-free production of well-defined poly(1-vinyl-2-pyrrolidone) for biomedical applications. RSC Adv. 2020, 10, 21593–21601. [Google Scholar] [CrossRef] [PubMed]
  34. Maksym, P.; Tarnacka, M.; Bernat, R.; Bielas, R.; Mielańczyk, A.; Hachuła, B.; Kaminski, K.; Paluch, M. Pressure-assisted strategy for the synthesis of vinyl pyrrolidone-based macro-star photoiniferters. A route to star block copolymers. J. Pol. Sci. 2020, 58, 1393–1399. [Google Scholar] [CrossRef]
  35. Chmiel, K.; Knapik-Kowalczuk, J.; Jurkiewicz, K.; Sawicki, W.; Jachowicz, R.; Paluch, M. A new method to identify physically stable concentration of amorphous solid dispersions (I): Case of flutamide + Kollidon VA64. Mol. Pharm. 2017, 14, 3370–3380. [Google Scholar] [CrossRef] [PubMed]
  36. Chmiel, K.; Knapik-Kowalczuk, J.; Paluch, M. How does the high pressure affects the solubility of the drug within the polymer matrix in solid dispersion systems. Eur. J. Pharm. Biopharm. 2019, 143, 8–17. [Google Scholar] [CrossRef]
  37. Chmiel, K.; Knapik-Kowalczuk, J.; Jachowicz, R.; Paluch, M. Broadband dielectric spectroscopy as an experimental alternative to calorimetric determination of the solubility of drugs into polymer matrix: Case of flutamide and various polymeric matrixes. Eur. J. Pharm. Biopharm. 2019, 136, 231–239. [Google Scholar] [CrossRef] [PubMed]
  38. Trivino, A.; Gumireddy, A.; Meng, F.; Prasad, D.; Chauhan, H. Drug–polymer miscibility, interactions, and precipitation inhibition studies for the development of amorphous solid dispersions for the poorly soluble anticancer drug flutamide. Drug Dev. Ind. Pharm. 2019, 45, 1277–1291. [Google Scholar] [CrossRef] [PubMed]
  39. Pacułt, J.; Rams-Baron, M.; Chmiel, K.; Jurkiewicz, K.; Antosik, A.; Szafraniec, J.; Kurek, M.; Jachowicz, R.; Paluch, M. How can we improve the physical stability of co-amorphous system containing flutamide and bicalutamide? The case of ternary amorphous solid dispersions. Eur. J. Pharm. Sci. 2021, 159, 105697. [Google Scholar] [CrossRef] [PubMed]
  40. Bielas, R.; Maksym, P.; Tarnacka, M.; Minecka, A.; Jurkiewicz, K.; Talik, A.; Geppert-Rybczyńska, M.; Grelska, J.; Mielańczyk, Ł.; Bernat, R.; et al. Synthetic strategy matters: The study of a different kind of PVP as micellar vehicles of metronidazole. J. Mol. Liq. 2021, 332, 115789. [Google Scholar] [CrossRef]
  41. Login, R.B. N-vinylamide polymers. In Encyclopedia of Chemical Technology; John Wiley & Sons: New York, NY, USA, 2001; p. 11. ISBN 978-0-47-148494-3. [Google Scholar]
  42. Cheng, H.N.; Smith, T.E.; Vitus, D.M. Tacticity of poly(N-vinyl pyrrolidone). J. Polym. Sci. Part C Polym. Lett. 1981, 19, 29–31. [Google Scholar] [CrossRef]
  43. Wan, D.; Satoh, K.; Kamigaito, M.; Okamoto, Y. Xanthate-mediated radical polymerization of N-vinylpyrrolidone in fluoroalcohols for simultaneous control of molecular weight and tacticity. Macromolecules 2005, 38, 10397–10405. [Google Scholar] [CrossRef]
  44. Satoh, K.; Kamigaito, M. Stereospecific living radical polymerization: Dual control of chain length and tacticity for precision polymer synthesis. Chem. Rev. 2009, 109, 5120–5156. [Google Scholar] [CrossRef] [PubMed]
  45. Dutta, K.; Brar, A.S. Poly(vinylpyrrolidone): Configurational assignments by one- and two-dimensional NMR spectroscopy. J. Polym. Sci. A Polym. Chem. 1999, 37, 3922–3928. [Google Scholar] [CrossRef]
  46. Hirano, T.; Miyamoto, Y.; Amano, S.; Tatsumi, K.; Anmoto, T.; Kimura, H.; Yoshida, M.; Oshimura, K.; Ute, K. Hydrogen-bond-assisted isotactic-specific radical polymerization of N-vinyl-2-pyrrolidone with tartrate additives in toluene at low temperatures: High-resolution 1H NMR analysis. RSC Adv. 2014, 4, 53079–53089. [Google Scholar] [CrossRef]
  47. Ebdon, J.R.; Huckerby, T.N.; Senogles, E. The influence of polymerization conditions on the tacticity of poly(N-vinyl-2-pyrrolidone). Polymer 1983, 24, 339–343. [Google Scholar] [CrossRef]
  48. Walling, C.; Tanner, D.D. Organic reactions under high pressure. IX. The effect of pressure on the stereochemistry of methyl methacrylate polymerization. J. Polym. Sci. 1963, 1, 2271–2277. [Google Scholar] [CrossRef]
  49. Rzayev, J.; Penelle, J. Polymerization of sterically congested α-alkylacrylates under high pressure. J. Polym. Sci. A Polym. Chem. 2002, 40, 836–843. [Google Scholar] [CrossRef]
  50. Biros, J.; Larina, T.; Trekoval, J.; Pouchly, J. Dependence of the glass transition temperature of poly(methyl methacrylates) on their tacticity. Colloid Polym. Sci. 1982, 260, 27–30. [Google Scholar] [CrossRef]
  51. Thompson, E.V. Dependence of the glass transition temperature of poly(methyl methacrylate) on tacticity and molecular weight. J. Polym. Sci. Part A Polym. Phys. 1966, 4, 199–208. [Google Scholar] [CrossRef]
  52. Chat, K.; Tu, W.; Beena Unni, A.; Adrjanowicz, K. Influence of tacticity on the glass transition dynamics of poly(methyl methacrylate) (PMMA) under elevated pressure and geometrical nanoconfinement. Macromolecules 2021, 54, 8526–8537. [Google Scholar] [CrossRef]
  53. Beiner, M. Relaxation in poly(alkyl methacrylate)s: Crossover region and nanophase separation. Macromol. Rapid Commun. 2001, 22, 869–895. [Google Scholar] [CrossRef]
  54. Negash, S.; Tatek, Y.B.; Tsige, M. Effect of tacticity on the structure and glass transition temperature of polystyrene adsorbed onto solid surfaces. J. Chem. Phys. 2018, 148, 134705. [Google Scholar] [CrossRef]
  55. Woo, E.M.; Chang, L. Tacticity in vinyl polymers. In Encyclopedia of Polymer Science and Technology; John Wiley & Sons: New York, NY, USA, 2002; Chapter 2; ISBN 978-1-11-863389-2. [Google Scholar]
  56. White, A.J.; Filisko, F.E. Isothermal enthalpy studies of poly(methyl methacrylate) stereoisomers and their blends. J. Appl. Phys. 1982, 53, 6563. [Google Scholar] [CrossRef]
  57. Chang, L.; Woo, E.M. Tacticity effects on glass transition and phase behavior in binary blends of poly(methyl methacrylate)s of three different configurations. Polym. Chem. 2010, 1, 198–202. [Google Scholar] [CrossRef]
  58. Kohlrausch, R. Ueber das dellmann’sche elektrometer. Ann. Phys. 1847, 72, 353–405. [Google Scholar] [CrossRef]
  59. Williams, G.; Watts, D.C. Non-symmetrical dielectric relaxation behaviour arising from a simple empirical decay function. Trans. Faraday Soc. 1970, 66, 80–85. [Google Scholar] [CrossRef]
  60. Kremer, F.; Schönhals, A. Broadband Dielectric Spectroscopy; Springer: Berlin, Germany, 2003. [Google Scholar]
  61. Chan, T.W.; Shyu, G.D.; Isayev, A.I. Master curve approach to polymer crystallization kinetics. Polym. Eng. Sci. 1995, 35, 733–740. [Google Scholar] [CrossRef]
  62. Avrami, M. Kinetics of phase change. I General theory. J. Chem. Phys. 1939, 7, 1103–1112. [Google Scholar] [CrossRef]
  63. Avrami, M. Kinetics of Phase Change. II Transformation-time relations for random distribution of nuclei. J. Chem. Phys. 1940, 8, 212–224. [Google Scholar] [CrossRef]
  64. Wunderlich, B. Macromolecular Physics, Vol 2. In Crystal Nucleation, Growth, Annealing; Academic Press: London, UK, 1976. [Google Scholar]
  65. Bahri, K.; Eslami, H.; Müller-Plathe, F. Self-assembly of model triblock Janus colloidal particles in two dimensions. J. Chem. Theory Comput. 2022, 18, 1870–1882. [Google Scholar] [CrossRef]
  66. Eslami, H.; Gharibi, A.; Müller-Plathe, F. Mechanisms of nucleation and solid–solid-phase transitions in triblock Janus assemblies. J. Chem. Theory Comput. 2021, 17, 1742–1754. [Google Scholar] [CrossRef]
  67. Romano, F.; Sciortino, F. Crystal phases of two dimensional assembly of triblock Janus particles. Soft Matter 2011, 7, 5799–5804. [Google Scholar] [CrossRef]
  68. Ten Wolde, P.R.; Frenkel, D. Enhancement of protein crystal nucleation by critical density fluctuations. Science 1997, 277, 1975–1978. [Google Scholar] [CrossRef]
  69. Lee, S.; Teich, E.G.; Engel, M.; Glotzer, S.C. Entropic colloidal crystallization pathways via fluid-fluid transitions and multidimensional prenucleation motifs. Proc. Natl. Acad. Sci. USA 2019, 116, 14843–14851. [Google Scholar] [CrossRef]
  70. Pouget, E.M.; Bomans, P.H.H.; Goos, J.A.C.M.; Frederik, P.M.; de With, G.; Sommerdijk, N.A.J.M. The initial stages of template-controlled CaCO3 formation revealed by cryo-TEM. Science 2009, 323, 1455–1458. [Google Scholar] [CrossRef] [PubMed]
  71. Augis, J.A.; Bennett, J.E. Calculation of the Avrami parameters for heterogeneous solid state reactions using a modified the Kissinger method. J. Therm. Anal. 1978, 13, 283–292. [Google Scholar] [CrossRef]
  72. Kissinger, H.E. Variation of peak temperature with heating rate in differential thermal analysis. J. Res. Natl. Bur. Stand. 1956, 57, 217–221. [Google Scholar] [CrossRef]
  73. Kołodziejczyk, K.; Tarnacka, M.; Kaminska, E.; Kaminski, K.; Paluch, M. Crystallization kinetics under confinement. Manipulation of the crystalline form of salol by varying pore diameter. Cryst. Growth Des. 2016, 16, 1218–1227. [Google Scholar] [CrossRef]
  74. Minecka, A.; Tarnacka, M.; Jurkiewicz, K.; Hachuła, B.; Wrzalik, R.; Kaminski, K.; Paluch, M.; Kaminska, E. The impact of the chain length and topology of the acetylated oligosaccharide on the crystallization tendency of naproxen from amorphous binary mixtures. Mol. Pharm. 2021, 18, 347–358. [Google Scholar] [CrossRef]
  75. Kolodziejczyk, K.; Paluch, M.; Grzybowska, K.; Grzybowski, A.; Wojnarowska, Z.; Hawelek, L. Relaxation dynamics and crystallization study of sildenafil in the liquid and glassy states. Mol. Pharm. 2013, 10, 2270–2282. [Google Scholar] [CrossRef]
  76. Dołęga, A.; Zieliński, P.M. Kinetics of non-isothermal cold-crystallization of carbamazepine in the glassy state studied by DSC. J. Non-Cryst. Solids 2022, 575, 121198. [Google Scholar] [CrossRef]
  77. Schammé, B.; Couvrat, N.; Malpeli, P.; Delbreilh, L.; Dupray, V.; Dargent, É.; Coquerel, G. Crystallization kinetics and molecular mobility of an amorphous active pharmaceutical ingredient: A case study with Biclotymol. Int. J. Pharm. 2015, 490, 248–257. [Google Scholar] [CrossRef]
  78. Wicaksono, Y.; Setyawan, D.; Nugraha, A.S.; Siswandono, S. Thermal behavior of cocrystal: A case study of ketoprofen-malonic acid and ketoprofen-nicotinamide cocrystals. Sains Malays. 2020, 49, 2679–2687. [Google Scholar] [CrossRef]
  79. Cense, J.M.; Agafonov, V.; Ceolin, R.; Ladure, P.; Rodier, N. Crystal and molecular structure analysis of flutamide. Bifurcated helicoidal C-H O hydrogen bonds. Struct. Chem. 1994, 5, 79–84. [Google Scholar] [CrossRef]
  80. Mariappan, G.; Sundaraganesan, N. Spectral and structural studies of the anti-cancer drug Flutamide by density functional theoretical method. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 2014, 117, 604–613. [Google Scholar] [CrossRef] [PubMed]
  81. Washio, I.; Xiong, Y.; Yin, Y.; Xia, Y. Reduction by the end groups of poly(vinyl pyrrolidone): A new and versatile route to the kinetically controlled synthesis of Ag triangular nanoplates. Adv. Mater. 2006, 18, 1745–1749. [Google Scholar] [CrossRef]
Figure 1. Chemical structures of flutamide (FL) and two polymers: poly-N-vinylpyrrolidone (PVP) and hydroxyl-terminated PVP (PVP-OH).
Figure 1. Chemical structures of flutamide (FL) and two polymers: poly-N-vinylpyrrolidone (PVP) and hydroxyl-terminated PVP (PVP-OH).
Pharmaceuticals 15 00971 g001
Figure 2. DSC thermograms collected for neat FL and FL-polymer BMs with 10% and 30% content of the excipient (panels (ad)). In the insets, DSC curves of neat PVPcomm, PVP Mn = 190 kg/mol, PVP-OH Mn = 190 kg/mol and PVP Mn = 90 kg/mol are also shown. Panel (e) presents the glass transition temperatures (TgDSC) of the examined binary systems (with 10 and 30% polymer content). A black square denotes TgDSC of neat FL.
Figure 2. DSC thermograms collected for neat FL and FL-polymer BMs with 10% and 30% content of the excipient (panels (ad)). In the insets, DSC curves of neat PVPcomm, PVP Mn = 190 kg/mol, PVP-OH Mn = 190 kg/mol and PVP Mn = 90 kg/mol are also shown. Panel (e) presents the glass transition temperatures (TgDSC) of the examined binary systems (with 10 and 30% polymer content). A black square denotes TgDSC of neat FL.
Pharmaceuticals 15 00971 g002
Figure 3. The content of triad fractions determined from β-methylene protons (13C NMR, D2O); mm—isotactic triad; mr—atactic triad; rr—syndiotactic triad.
Figure 3. The content of triad fractions determined from β-methylene protons (13C NMR, D2O); mm—isotactic triad; mr—atactic triad; rr—syndiotactic triad.
Pharmaceuticals 15 00971 g003
Figure 4. Representative dielectric loss spectra measured for neat FL (a) as well as FL+10 wt% PVP(PVP-OH) BMs at T > Tg (be). Panel (f) presents the differences between Tonset and Tg for FL (a black square) and examined binary systems with 10% content of the polymer: FL+PVPcomm. (a red circle), FL+PVP-OH Mn = 190 kg/mol (a blue inverse triangle), FL+PVP Mn = 190 kg/mol (a green triangle), FL+PVP Mn = 90 kg/mol (a violet star).
Figure 4. Representative dielectric loss spectra measured for neat FL (a) as well as FL+10 wt% PVP(PVP-OH) BMs at T > Tg (be). Panel (f) presents the differences between Tonset and Tg for FL (a black square) and examined binary systems with 10% content of the polymer: FL+PVPcomm. (a red circle), FL+PVP-OH Mn = 190 kg/mol (a blue inverse triangle), FL+PVP Mn = 190 kg/mol (a green triangle), FL+PVP Mn = 90 kg/mol (a violet star).
Pharmaceuticals 15 00971 g004
Figure 5. A comparison of the shape of the structural (α)-relaxation peak for FL and FL+polymer mixtures with 10 wt% of the latter component at T~Tg (a). The solid lines are KWW fits to the data. Temperature dependence of (α)-relaxation times for FL and examined BMs (b). The solid lines represent VFT fits.
Figure 5. A comparison of the shape of the structural (α)-relaxation peak for FL and FL+polymer mixtures with 10 wt% of the latter component at T~Tg (a). The solid lines are KWW fits to the data. Temperature dependence of (α)-relaxation times for FL and examined BMs (b). The solid lines represent VFT fits.
Pharmaceuticals 15 00971 g005
Figure 6. DSC curves obtained for FL (a) and its mixture with 10 wt% of PVP Mn = 190 kg/mol (b). Thermograms were measured with the indicated heating rates.
Figure 6. DSC curves obtained for FL (a) and its mixture with 10 wt% of PVP Mn = 190 kg/mol (b). Thermograms were measured with the indicated heating rates.
Pharmaceuticals 15 00971 g006
Figure 7. The relative degree of crystallinity (X) versus time for FL (a) and its mixture with 10 wt% of PVP Mn = 190 kg/mol (b). In panels (c,d), the dependences of the logarithm of the crystallization constant rates ( k 1 and k 2 , respectively) versus heating rate are shown.
Figure 7. The relative degree of crystallinity (X) versus time for FL (a) and its mixture with 10 wt% of PVP Mn = 190 kg/mol (b). In panels (c,d), the dependences of the logarithm of the crystallization constant rates ( k 1 and k 2 , respectively) versus heating rate are shown.
Pharmaceuticals 15 00971 g007
Figure 8. Augis and Bennett (a) and Kissinger (b) plots for exothermic crystallization peaks in neat FL, FL+PVPcomm., FL+PVP Mn = 90 kg/mol, FL+PVP Mn = 190 kg/mol and FL+PVP-OH binary mixtures. In panel (c), the values of crystallization energy (Ecr) determined for the examined systems from both approaches, along with the error bars (5%), are shown.
Figure 8. Augis and Bennett (a) and Kissinger (b) plots for exothermic crystallization peaks in neat FL, FL+PVPcomm., FL+PVP Mn = 90 kg/mol, FL+PVP Mn = 190 kg/mol and FL+PVP-OH binary mixtures. In panel (c), the values of crystallization energy (Ecr) determined for the examined systems from both approaches, along with the error bars (5%), are shown.
Pharmaceuticals 15 00971 g008
Figure 9. ATR-FTIR spectra of neat FL and its binary mixtures with different PVP and PVP-OH (with 10% polymer content) presented in the high- and low-frequency ranges (3800–2500 cm−1 and 1800–400 cm−1, respectively). The spectra were normalized to the maximum intensity of the C-H stretching vibration (2976 cm−1) and the N-C/F-C stretching vibrations (1139 cm−1).
Figure 9. ATR-FTIR spectra of neat FL and its binary mixtures with different PVP and PVP-OH (with 10% polymer content) presented in the high- and low-frequency ranges (3800–2500 cm−1 and 1800–400 cm−1, respectively). The spectra were normalized to the maximum intensity of the C-H stretching vibration (2976 cm−1) and the N-C/F-C stretching vibrations (1139 cm−1).
Pharmaceuticals 15 00971 g009
Table 1. Values of Tg obtained from BDS measurements as well as Tg and temperatures of the crystallization process (Tp, To) obtained from DSC thermograms collected at different heating rates ( ϕ ). Values of the rate constant (k1, k2) and Avrami exponent (n) obtained the fitting the data presented in Figure 7a (FL), Figure 7b and Figure S7 (FL+various PVP binary mixtures) using Equations (6) and (7), respectively, are also given.
Table 1. Values of Tg obtained from BDS measurements as well as Tg and temperatures of the crystallization process (Tp, To) obtained from DSC thermograms collected at different heating rates ( ϕ ). Values of the rate constant (k1, k2) and Avrami exponent (n) obtained the fitting the data presented in Figure 7a (FL), Figure 7b and Figure S7 (FL+various PVP binary mixtures) using Equations (6) and (7), respectively, are also given.
System ϕ (K/min) Tg BDS (K)Tg DSC (K) T p   ( K ) T o   ( K ) k1 (s−1)k2 (s−1)n
FL5---273313.7312.10.00527---1.3
10271274317.3316.20.01068---1.7
20---276322.8321.10.04113---2.2
30---278325.2322.90.06558---2.6
FL+10 wt% PVPcomm
Mn = 109 kg/mol
5---274318.9313.90.004990.002122.3
10272275322.6318.10.012060.005082.4
20---277330.1324.10.019160.009372.6
30---279336.2327.90.024330.013852.9
FL+10 wt% PVP
Mn = 90 kg/mol
5---277337.2330.20.004400.002832.8
10277279341.9334.10.007770.005352.9
20---281351.7341.90.016010.013013.0
30---283359.4348.10.022320.018412.9
FL+10 wt% PVP
Mn = 190 kg/mol
5---278333.1326.20.004150.002473.0
10276279337.1330.30.006830.004452.9
20---282347.3338.10.013020.009572.6
30---283355.8342.90.018140.013652.9
FL+10 wt% PVP-OH
Mn = 190 kg/mol
5---273317.5313.10.005170.002262.2
10274275321.7317.20.010100.004532.4
20---277329.3323.10.017050.008952.8
30---279336.2327.20.024490.016712.7
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Heczko, D.; Hachuła, B.; Maksym, P.; Kamiński, K.; Zięba, A.; Orszulak, L.; Paluch, M.; Kamińska, E. The Effect of Various Poly (N-vinylpyrrolidone) (PVP) Polymers on the Crystallization of Flutamide. Pharmaceuticals 2022, 15, 971. https://doi.org/10.3390/ph15080971

AMA Style

Heczko D, Hachuła B, Maksym P, Kamiński K, Zięba A, Orszulak L, Paluch M, Kamińska E. The Effect of Various Poly (N-vinylpyrrolidone) (PVP) Polymers on the Crystallization of Flutamide. Pharmaceuticals. 2022; 15(8):971. https://doi.org/10.3390/ph15080971

Chicago/Turabian Style

Heczko, Dawid, Barbara Hachuła, Paulina Maksym, Kamil Kamiński, Andrzej Zięba, Luiza Orszulak, Marian Paluch, and Ewa Kamińska. 2022. "The Effect of Various Poly (N-vinylpyrrolidone) (PVP) Polymers on the Crystallization of Flutamide" Pharmaceuticals 15, no. 8: 971. https://doi.org/10.3390/ph15080971

APA Style

Heczko, D., Hachuła, B., Maksym, P., Kamiński, K., Zięba, A., Orszulak, L., Paluch, M., & Kamińska, E. (2022). The Effect of Various Poly (N-vinylpyrrolidone) (PVP) Polymers on the Crystallization of Flutamide. Pharmaceuticals, 15(8), 971. https://doi.org/10.3390/ph15080971

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop